Format

Send to

Choose Destination
Obes Surg. 2018 May;28(5):1351-1362. doi: 10.1007/s11695-017-3015-9.

Detailed Description of Change in Serum Cholesterol Profile with Incremental Weight Loss After Restrictive Bariatric Surgery.

Author information

1
Centre for Obesity Research and Education, Department of Surgery, Central Clinical School, Monash University, Level 6, 99 Commercial Road, Melbourne, 3181, Australia. geraldineooi@gmail.com.
2
Department of Surgery, Alfred Hospital, Melbourne, Australia. geraldineooi@gmail.com.
3
Department of Epidemiology and Preventative Medicine, School of Public Health and Preventative Medicine, Monash University, Melbourne, Australia.
4
Centre for Obesity Research and Education, Department of Surgery, Central Clinical School, Monash University, Level 6, 99 Commercial Road, Melbourne, 3181, Australia.
5
Walter and Eliza Hall Institute, Melbourne University, Melbourne, Australia.
6
Melbourne Pathology, East Melbourne, Australia.
7
Diabetes Complications Research Centre, University College, Dublin, Ireland.
8
Department of Surgery, Alfred Hospital, Melbourne, Australia.

Abstract

INTRODUCTION:

Dyslipidemia affects up to 75% of morbidly obese individuals and is a key driver of cardiovascular disease. Weight loss is an established strategy to improve metabolic risk, including dyslipidemia. We aimed to determine weight loss goals for resolution of serum lipid abnormalities, by measuring improvements during progressive weight loss in obese individuals.

METHODS:

We performed a prospective cohort study of obese individuals with the metabolic syndrome undergoing adjustable gastric banding. Lipid levels were monitored monthly for 9 months, then three monthly until 24 months.

RESULTS:

There were 101 participants included, age 47.4 ± 10.9 years with body mass index 42.6 ± 5.9 kg/m2. At 24 months, total body weight loss (TBWL) was 18.3 ± 7.9%. This was associated with significant improvements in high-density lipoprotein (HDL) (1.18 vs 1.47, p < 0.001), triglyceride (2.0 vs 1.4, p < 0.001), and total cholesterol to HDL ratio (TC:HDL) (4.6 vs 3.6, p < 0.001). Over this time, progressive and linear improvements in HDL, triglycerides, and TC:HDL were seen with incremental weight loss (observed at 2.5% TBWL intervals). Significant improvements occurred after a threshold weight loss of 7.5-12.5% TBWL was achieved, with odds ratio (OR) 1.48-2.50 for normalization. These odds improved significantly with increasing weight loss (OR 18.2-30.4 with > 25% TBWL). Despite significant weight loss, there was no significant change in low-density lipoprotein (LDL).

CONCLUSION:

Significant improvements in triglycerides, HDL, and TC:HDL occur after 7.5-12.5% TBWL, with ongoing benefit after greater weight loss. LDL needs to be addressed independently, as this was not observed to respond to weight loss alone.

TRIAL REGISTRATION NUMBER:

Australian Clinical Trials Registry (ACTRN12610000049077).

KEYWORDS:

Bariatric surgery; Cholesterol; Dyslipidemia; Insulin resistance; Lipoproteins; Triglycerides; Weight loss

PMID:
29159554
DOI:
10.1007/s11695-017-3015-9

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center